Segall Bryant & Hamill’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.13M | Sell |
22,728
-19,641
| -46% | -$6.16M | 0.1% | 274 |
|
|
2025
Q1 | $12.9M | Buy |
42,369
+16,872
| +66% | +$5.14M | 0.2% | 158 |
|
|
2024
Q4 | $8.47M | Sell |
25,497
-4,527
| -15% | -$1.5M | 0.12% | 255 |
|
|
2024
Q3 | $10M | Sell |
30,024
-30,888
| -51% | -$10.3M | 0.14% | 232 |
|
|
2024
Q2 | $25.1M | Buy |
60,912
+5,222
| +9% | +$2.15M | 0.44% | 70 |
|
|
2024
Q1 | $22.5M | Sell |
55,690
-11,365
| -17% | -$4.59M | 0.42% | 81 |
|
|
2023
Q4 | $20.6M | Buy |
67,055
+14,126
| +27% | +$4.33M | 0.4% | 83 |
|
|
2023
Q3 | $12.8M | Buy |
52,929
+406
| +0.8% | +$98.3K | 0.15% | 184 |
|
|
2023
Q2 | $12.6M | Buy |
52,523
+158
| +0.3% | +$37.9K | 0.13% | 199 |
|
|
2023
Q1 | $9.85M | Buy |
52,365
+317
| +0.6% | +$59.6K | 0.11% | 233 |
|
|
2022
Q4 | $11.1M | Sell |
52,048
-15,657
| -23% | -$3.33M | 0.12% | 205 |
|
|
2022
Q3 | $10.6M | Sell |
67,705
-7,917
| -10% | -$1.24M | 0.13% | 197 |
|
|
2022
Q2 | $11.3M | Buy |
75,622
+9,733
| +15% | +$1.46M | 0.13% | 181 |
|
|
2022
Q1 | $10.8M | Buy |
65,889
+45,912
| +230% | +$7.51M | 0.1% | 207 |
|
|
2021
Q4 | $4.35M | Sell |
19,977
-3,586
| -15% | -$780K | 0.04% | 336 |
|
|
2021
Q3 | $4.46M | Sell |
23,563
-241
| -1% | -$45.6K | 0.04% | 353 |
|
|
2021
Q2 | $4.21M | Sell |
23,804
-663
| -3% | -$117K | 0.04% | 359 |
|
|
2021
Q1 | $4.02M | Buy |
+24,467
| New | +$4.02M | 0.04% | 377 |
|